|
1. |
Detection of hypodiploidy using multi‐parameter flow cytometric analysis: A prognostic indicator in multiple myeloma |
|
American Journal of Hematology,
Volume 30,
Issue 4,
1989,
Page 195-200
Robert J. Morgan,
Nick J. Gonchoroff,
Jerry A. Katzmann,
Thomas E. Witzig,
Robert A. Kyle,
Philip R. Greipp,
Preview
|
PDF (464KB)
|
|
摘要:
AbstractWe analyzed 49 patients with multiple myeloma (MM) using propidium iodide (PI) staining and flow cytometry to assess DNA content of MM cells in bone marrow. In 12 patients the presence or absence of DNA content aneuploidy could not be determined by analysis of single‐parameter DNA histograms alone. Using forward light scatter measurement, resolution of ploidy was readily obtained in all but three cases. Assuming the DNA content of the low light scatter population to be diploid, we were able to classify 7 cases as hypodiploid and 39 as hyperdiploid or diploid. Hyperdiploid or diploid patients survived a median of 24 months and hypodiploid patients only 2.5 months. We conclude that multiparameter analysis of DNA content and light scatter provides easier analysis for the presence or absence of aneuploidy. Patients with DNA content hypodiploidy have a short surviva
ISSN:0361-8609
DOI:10.1002/ajh.2830300402
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1989
数据来源: WILEY
|
2. |
Red cell ferritin and iron overload in heterozygous beta‐thalassemia |
|
American Journal of Hematology,
Volume 30,
Issue 4,
1989,
Page 201-205
Martin B. van der Weyden,
Hubert Fong,
Lynnette J. Hallam,
Christine Harrison,
Preview
|
PDF (447KB)
|
|
摘要:
AbstractRed cell ferritin was evaluated in 101 individuals with heterozygous beta‐thalassemia to determine its clinical utility as an index for iron deficiency or overload in these subjects. The mean red cell ferritin for the total population was elevated threefold and showed a significant correlation with transferrin saturation, plasma ferritin, and HbA2 levels. Five of six subjects with reduced red cell ferritin had associated iron deficiency; a further five had iron deficiency and normal red cell ferritin. Normal red cell ferritin occurred in 51 subjects, and 44 had increased values. In the elevated red cell ferritin group, 21 individuals had associated normal plasma ferritin, and 23 had increased plasma ferritin. Only in the latter group was red cell ferritin significantly correlated with transferrin saturation and plasma ferritin. Ten individuals had a red cell ferritin ≤ 150 attogram/cell, and liver biopsy performed in four showed grades II to IV iron overload. A clinical feature of subjects with both increased red cell and plasma ferritin levels was a high incidence of inappropriate iron administration. These findings suggest that red cell ferritin, particularly when combined with plasma ferritin, is a useful parameter for determining potential iron overload in individuals with heterozygous beta‐thalas
ISSN:0361-8609
DOI:10.1002/ajh.2830300403
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1989
数据来源: WILEY
|
3. |
Platelet survival and turnover: Important factors in predicting response to splenectomy in immune thrombocytopenic purpura |
|
American Journal of Hematology,
Volume 30,
Issue 4,
1989,
Page 206-212
Robert S. Siegel,
Janice L. Rae,
Susan Barth,
R. Edward Coleman,
Richard C. Reba,
Roger Kurlander,
Wendell F. Rosse,
Preview
|
PDF (584KB)
|
|
摘要:
AbstractAutologous indium‐111 platelet sequestration and survival studies were performed on 59 immune thrombocytopenic purpura (ITP) patients, 21 of whom underwent splenectomy shortly thereafter. Sequestration patterns were primarily splenic in 46 patients, primarily hepatic in 6 patients, and both splenic and hepatic in 8 patients. The mean platelet survival ranged from 15 to 211 hr (normal, 180‐220 hr), and mean platelet turnover (a measure of platelet production rate) varied from 99 platelets/μl/hr to 7,585 platelets/μl/hr (normal 1,200‐1,600 platelets/μl/hr). Among splenectomy patients, 13 had an excellent response, and 8 had a fair or poor response. Neither the pattern of platelet sequestration nor the quantity of platelet‐associated IgG was useful in predicting response to splenectomy. There was, however, a striking correlation between platelet studies showing short survival/high turnover and subsequent excellent responses to splenectomy. Conversely, patients with only moderately decreased survival and low turnover had an unpredictable response to splenectomy. This investigation demonstrates that ITP patients are a heterogeneous population and include a significant subset whose thrombocytopenia results primarily from decreased turnover. Platelet kinetic studies appear useful in predicting beneficial response to s
ISSN:0361-8609
DOI:10.1002/ajh.2830300404
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1989
数据来源: WILEY
|
4. |
Comparison of laboratory tests used for identification of the lupus anticoagulant |
|
American Journal of Hematology,
Volume 30,
Issue 4,
1989,
Page 213-220
Samuel C. L. Lo,
Michael J. Oldmeadow,
Margaret A. Howard,
Barry G. Firkin,
Preview
|
PDF (704KB)
|
|
摘要:
AbstractA comparison of the sensitivities of the ten most commonly used tests for the identification of the lupus anticoagulant (LA) and the lupus cofactor phenomenon was undertaken on 18 patients. All investigations, except the cardiolipin‐antibody ELISA assay, were carried out using patient's plasma alone followed by a 1:1 mix with control plasma. Dilution studies (1:3, 1:6, 1:9—patient:control) were also carried out. The kaolin clotting time (KCT) was the only test positive in all patients at all dilutions, while the dilute activated partial thromboplastin time with kaolin (Dil‐APTT) registered 17 of 18 positive at all dilutions. Both the dilute Russell viper venom time (Dil‐RVVT) and the tissue thromboplastin inhibition time (TTI) (1/500 thromboplastin) identified the LA in 17 of 18 patients on initial testing but were less sensitive in the dilution studies. The KCT is not a suitable test for routine laboratory use, as it requires an individual filtration step. Therefore a combination of either the Dil‐APTT or Dil‐RVVT together with the TTI (1/500 dilution thromboplastin) is recommended for routine LA screening, as all patients with LA in this study were identified using these easily automated tests. The lupus cofactor phenomenon was most frequently demonstrated using t
ISSN:0361-8609
DOI:10.1002/ajh.2830300405
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1989
数据来源: WILEY
|
5. |
Morphologic and cytochemical characteristics of acute promyelocytic leukemia |
|
American Journal of Hematology,
Volume 30,
Issue 4,
1989,
Page 221-227
F. R. Davey,
R. B. Davis,
J. M. Maccallum,
D. A. Nelson,
R. J. Mayer,
E. D. Ball,
J. D. Griffin,
C. A. Schiffer,
C. D. Bloomfield,
Preview
|
PDF (1017KB)
|
|
摘要:
AbstractThe existence of two distinct subtypes of acute promyelocytic leukemia was confirmed and characterized based on morphologic features of leukemic cells in a series of 63 patients studied by the Cancer and Leukemia Group B (CALGB). Seventeen patients (27%) had microgranular leukemic cells (M3V), and 46 patients (73%) had hypergranular leukemic cells (M3). These patient cohorts were studied for other laboratory and clinical features. Leukemic cells from M3V patients stained less frequently than leukemic cells from M3 patients for myeloperoxidase (median, 93% vs. 99%;P=.006), periodic acid‐Schiff (median, 57% vs. 92%;P=.0001), ASD‐chloroacetate esterase (median, 45% vs. 87%;P<.0001), and alpha‐naphthyl acetate esterase (0% vs. 37%;P=.003). Patients with M3V had a higher platelet count (median, 50 vs. 30 × 109/L;P=.01) and tended to have a higher leukocyte count (median, 7.4 vs. 2.2 × 109/L;P=.06) than M3 patients. The patients with M3V morphology were more likely to be nonwhite (29% vs. 7%;P=.03), female (71% vs. 37%;P=.02), and to be infected at the time of presentation (71% vs. 35%;P=.02). No differences in the frequency of the t(15;17) karyotype or the immunopheno‐typic expression of the leukemic cells were noted in the two morphologic subtypes of acute promyelocytic leukemia. Fewer patients with M3V tended to enter complete remission (65% vs. 80%;P=.20), but no significant differences were found in the duration of complete remission (P=.81; 1 year rate, 50% vs. 85%), or probability of survival (P=.67; 1 year rate, 49%
ISSN:0361-8609
DOI:10.1002/ajh.2830300406
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1989
数据来源: WILEY
|
6. |
HLA antibody formation within the HLA‐A1 crossreactive group in multitransfused platelet recipients |
|
American Journal of Hematology,
Volume 30,
Issue 4,
1989,
Page 228-232
Bruce R. Macpherson,
Preview
|
PDF (467KB)
|
|
摘要:
AbstractThe formation of intragroup antibodies, HLA antibodies directed against antigens in the same crossreactive group (CREG) as those of the serum donor, may be an important cause of transfusion failures in patients receiving HLA‐matched platelets. Twenty‐two patients whose HLA types included at least one antigen in the HLA‐A1 CREG were studied. Of the ten patients who formed HLA antibodies, six produced antibodies that reacted with one or more antigens in the HLA‐A1 CREG. Five of 12 patients whose HLA types included HLA‐A3 formed antibodies directed against HLA‐A1‐10‐11 or HLA‐A1‐10. In contrast, only one of ten individuals whose phenotypes included HLA‐A1, HLA‐A11, or both produced anti‐HLA‐A3. Eleven incompatible retrospective crossmatches were observed in recipients of HLA‐matched platelets attributable to intragroup antibodies. Patients receiving incompatible platelets had unsatisfactory post‐transfusion platelet count increments. It is concluded that intragroup antibodies, such as those directed against antigens in the HLA‐A1 CREG, are an important cause of platelet transfusion failures in patients requiring long‐term platelet transfusion support. These antibodies can be identified by routinely screening recipient sera for HLA antibodies and performing retrospective crossmatches usi
ISSN:0361-8609
DOI:10.1002/ajh.2830300407
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1989
数据来源: WILEY
|
7. |
8;21 translocation in myelodysplasia secondary to essential thrombocythemia |
|
American Journal of Hematology,
Volume 30,
Issue 4,
1989,
Page 233-235
Elaine Knottenbelt,
Janet Hallett,
Peter Jacobs,
Preview
|
PDF (243KB)
|
|
摘要:
AbstractA case is presented of a 73‐year‐old woman who received busulphan for essential thrombocythemia and subsequently developed a myelodysplastic syndrome (MDS), which transformed to acute nonlymphoblastic leukaemia within 1 month. Cytogenetic studies showed a 46,XX,t(8;21) (q22;q22) karyotype in all metaphases examined at diagnosis. The karyotypic abnormality is previously unreported in secondary myelodysplasia and may have specific clinical implications in this setting, such as early transformation to acute leukaemia and short survival. This finding contrasts with the generally favourable prognosis of the 8;21 translocation in patients with de novo acute nonlymphoblastic leukemia. A possible explanation for this difference may be the involvement of a committed progenitor in acute nonlymphoblastic leukaemia, while in myelodysplasia the more primitive multipotent stem cell may be affec
ISSN:0361-8609
DOI:10.1002/ajh.2830300408
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1989
数据来源: WILEY
|
8. |
Thrombocytopenia associated with auranofin therapy: Evidence for a gold‐dependent immunologic mechanism |
|
American Journal of Hematology,
Volume 30,
Issue 4,
1989,
Page 236-239
Michael P. Kosty,
P. Kahler Hench,
Patricia Tani,
Robert McMillan,
Preview
|
PDF (287KB)
|
|
摘要:
AbstractThrombocytopenia associated with gold therapy is thought to be due to an immunemediated mechanism. Relatively few patients have been studied so far, and precise details of the pathophysiology of this disease remain undetermined. We report a patient with gold‐induced thrombocytopenia resulting from auranofin therapy. The patient's plasma contained platelet‐reactive antibodies detectable only in the presence of gold salts. Antibody binding occurred at gold concentrations ranging from 0.01 to 10,000 ng/ml. The binding occurred independently of gold salt used, suggesting that substitution of a different gold preparation in this patient would result in a similar thrombocytopenia. These data support a drug‐dependent immune mechanism for platelet destru
ISSN:0361-8609
DOI:10.1002/ajh.2830300409
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1989
数据来源: WILEY
|
9. |
Hybrid acute leukemia in an HIV‐antibody‐positive patient |
|
American Journal of Hematology,
Volume 30,
Issue 4,
1989,
Page 240-247
Jay E. Gold,
Arvid Babu,
Victor Penchaszadeh,
Antonio Castella,
Violette Ghali,
Ralph Zalusky,
Preview
|
PDF (1449KB)
|
|
摘要:
AbstractAlthough the great majority of acute leukemias have been designated as being of lymphocytic or myelocytic origin, recent reports have described elements of both in some patients. We describe here the first case of hybrid acute leukemia in an HIV‐antibody‐positive patient as well as the first hybrid involving B‐cell (Burkitt) acute lymphocytic leukemia and acute myelomonocytic leukemia proven by cytochemical, immunologic, and cytogenetic methods. This case illustrates the increasingly complex difficulties in the diagnosis and treatment of AIDS‐related malig
ISSN:0361-8609
DOI:10.1002/ajh.2830300410
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1989
数据来源: WILEY
|
10. |
Reversal of bone marrow fibrosis and subsequent development of polycythemia in patients with myeloproliferative disorders |
|
American Journal of Hematology,
Volume 30,
Issue 4,
1989,
Page 248-253
Lilia Talarico,
Barbara C. Wolf,
Aruna Kumar,
Lewis R. Weintraub,
Preview
|
PDF (1671KB)
|
|
摘要:
AbstractBone marrow fibrosis is a characteristic finding in agnogenic myeloid metaplasia and in the spent phase of polycythemia vera. It is commonly believed that the reticulin deposition is irreversible. However, we report four patients who demonstrated clinical and laboratory evidence of transition from myelofibrosis to polycythemia. The transition was documented by improvement in the hemoglobin concentration and by determination of the Cr51red blood cell mass, accompanied by a resolution of the fibrosis on serial bone marrow biopsies. Two of the patients had been treated with alkylating agents and splenectomy, one with myelosuppressive therapy without splenectomy, and one with splenectomy alone. These findings indicate that bone marrow fibrosis in the chronic myeloproliferative disorders is not always an irreversible phenomenon. Pathogenetic implications will be discussed.
ISSN:0361-8609
DOI:10.1002/ajh.2830300411
出版商:Wiley Subscription Services, Inc., A Wiley Company
年代:1989
数据来源: WILEY
|
|